Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo

European Journal of Pharmacology

Volumn 340, Issue 1, 1997, Pages 53-58

  Gainetdinov, Raul R ^a,b   Sotnikova, Tatyana D ^a   Grekhova, Tatyana V ^a   Rayevsky, Kirill S ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine release; Microdialysis; Psychostimulant drug; Sydnocarb

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; PSYCHOSTIMULANT AGENT; SYDNOCARB;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; FACILITATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STEREOTYPY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIDEPRESSIVE AGENTS; CALCIUM; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOVANILLIC ACID; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; SYDNONES; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

EID: 0031553383     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01407-6     Document Type: Article

References (25)

1. Altshuler R.A., Mashkovsky M.D., Rotchina L.F. Sydnocarb - a new stimulant of central nervous system (In Russian). Farmakol. Toxikol. 36:1973;18-22.
2. Avrutsky, G.Ya., Neduva, A.A., 1988. Treatment of psychiatric patients (in Russian). Medicina, Moscow.
3. Butcher S.P., Fairbrother I.C., Kelly J.S., Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum: An in vivo microdialysis study. J. Neurochem. 50:1988;346-355.
4. Butcher S.P., Liptrot J., Arbuthnott G.W. Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122:1991;245-248.
5. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-662.
6. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
7. Erdo S.L., Kiss B., Rosdy B. Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb). Polish J. Pharmacol. Pharm. 33:1981;141-147.
8. 3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol. 261:1994;327-331.
9. Hurd Y.L., Ungerstedt U. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166:1989;251-260.
10. Ichikawa J., Meltzer H.Y. Amperozide, a novel antipsychotic drug, inhibits the ability of D-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens. J. Neurochem. 58:1992;2285-2291.
11. 2 receptor-mediated function: Behavioral indices. Eur. J. Pharmacol. 186:1990;79-86.
12. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology. 2:1989;273-279.
13. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse. 6:1990;106-112.
14. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur. J. Pharmacol. 195:1991;63-73.
15. Paxinos, G., Watson, C., 1982. The Rat Brain Stereotaxic Coordinates. Academic Press, Sydney.
16. Rayevsky K.S., Sotnikova T.D., Grekhova T.V., Gainetdinov R.R. Sydnocarb, an original psychostimulant, differs from amphetamine in respect to brain dopaminergic transmission: Behavioral and microdialysis study in rats. Pharmacol. Res. 31 (Supplement):1995;30.
17. Robinson T.E., Camp D.M. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology. 3:1990;163-173.
18. Ross S.B. The central stimulatory action of the inhibitors of the dopamine uptake. Life Sci. 24:1979;159-167.
19. Rudenko G.M., Altshuler R.A. Peculiarities of clinical activity and pharmacokinetics of sydnocarb (sydnocarbum), an original psychostimulant. Agressologie. 20:1979;265-270.
20. Sharp T., Zetterström T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
21. Sotnikova T.D., Gainetdinov R.R., Grekhova T.V., Rayevsky K.S. Effect of original psychostimulant drug sydnocarb on brain dopaminergic transmission: Behavioral and in vivo microdialysis study in rats. Behav. Pharmacol. 6(Suppl. 1):1995;28-29.
22. Westerink B.H.C., Damsma G., De Vries J.B., Koning H. Dopamine re-uptake inhibitors show inconsistent effects on in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur. J. Pharmacol. 135:1987;123-128.
23. Westerink B.H.C., Tuntler J., Damsma G., Rollema H., De Vries J.B. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;502-507.
24. Westerink B.H.C., Hofsteede R.M., Tuntler J., De Vries J.B. Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J. Neurochem. 52:1989;722-729.
25. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in striatum after various dopamine-releasing drugs: Implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334.